A Breakthrough Treatment for Chronic Neuropathic Pain
Axon Therapy® mPNS, 100% noninvasive treatment device for chronic nerve pain.
Axon Therapy magnetic Peripheral Nerve Stimulation (mPNS) represents a paradigm shift for treating chronic neuropathic pain. Discover the electroceutical platform rewriting the approach to neuromodulation.
Magnetic Peripheral Nerve Stimulation
(mPNS)
Magnetic Peripheral Nerve Stimulation (mPNS)
for Chronic Pain. J Pain Res. 2023;16 : 2365-2373
AXON THERAPY mPNS AT A GLANCE
What if You Could Treat More
Patients With Neuromodulation?
Axon Therapy mPNS is changing lives every day without needles, scalpels, implants, or ablations. With our noninvasive therapy designed to reduce pain, you can expand the benefits of neuromodulation to a larger patient community.
THE AXON ADVANTAGE
Welcome to a Turning
Point in Chronic Pain
Management
Axon Therapy mPNS represents the first completely noninvasive neuromodulation platform. With its high-intensity magnetic field, mPNS can be administered at skin level or even above skin level. There are no leads, no injections, no surgical implants, no risks of infection, and no therapeutic interruptions due to lead fracture or battery issues.
After only one treatment, Axon Therapy mPNS begins reconditioning the central nervous system by eliminating noxious pain signals to the brain. By contrast to conventional PNS, Axon Therapy uses magnetic stimulation to engage sensory, pain, and motor fibers mechanistically, providing long-term relief for the root cause of post-trauma and post-surgical neuropathic pain.
Until Axon Therapy mPNS, treating chronic neuropathic pain generally boiled down to medications or intervention. Now, with its innovative mechanism of action, Axon Therapy mPNS offers a more stepwise approach to patient management compared to more intensive forms of neuromodulation such as PNS.
Axon Therapy represents a breakthrough for chronic neuropathic pain management that can minimize dependence on opioids and other medications with potentially adverse side effects by an average of 51%. Improving quality of life for patients, while mitigating the risks of opioid addiction and overdose.
We’re the first to configure a high-intensity magnetic field into such a small physical footprint. It’s the only mPNS mechanism of action that is FDA-cleared for chronic intractable pain, post-surgical pain, post-traumatic pain, and painful diabetic neuropathy of the lower extremities. With ongoing clinical research, we’re confident it will gain FDA clearance for even more indications.
We’re a team of doctors, scientists, advisors, and veterans with a unique blend of expertise in pain management. Our vast experience in neuromodulation technology and chronic neuropathic pain treatment emboldens our mission to free the world from chronic neuropathic suffering.
SIGNIFICANT CLINICAL TRIAL RESULTS
The Treatment is Simple.
The Results Are Profound.
The Neuralace SEAT (Safety and Efficacy of Axon Therapy) RCT demonstrates significant effects at the 90-day primary endpoint, with both the physics and mechanism of action supported by hard data.
ABOUT US
With Every Magnetic
Pulse, We’re Changing
Lives
Find Out More About Axon Therapy mPNS
